PHARMING GRP SP. ADRS (PHG) — Cash Flow Reinvestment Rate
PHARMING GRP SP. ADRS (PHG) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €502.00K (capex €269.00K plus investments €233.00K) from operating cash flow of €10.71 Million. See PHARMING GRP SP. ADRS (PHG) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PHARMING GRP SP. ADRS Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for PHARMING GRP SP. ADRS across 3 annual periods. For the full cash flow conversion analysis, see PHARMING GRP SP. ADRS cash conversion from operations.
Annual Cash Flow Reinvestment Rate for PHARMING GRP SP. ADRS (2021–2025)
Year-by-year capital reinvestment analysis for PHARMING GRP SP. ADRS. See financial agility of PHARMING GRP SP. ADRS to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | €85.98 Million | €54.71 Million | €755.00K | ▲ +1685.3% |
| 2022 | 0.09x | €1.98 Million | €22.46 Million | €1.98 Million | ▼ -84.4% |
| 2021 | 0.56x | €21.30 Million | €37.84 Million | €16.72 Million | — |